Fusion Pharmaceuticals Inc.
FUSNDelisted Jun 5, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001805890
Fusion Pharmaceuticals Inc. was delisted on Jun 5, 2024; its insiders filed their last Form 4 on Jun 4, 2024; 114 institutions reported holding it in 13F filings for Q1 2024, worth $1.47B in total; Duquesne Family Office was the only superinvestor holding it.
Holders of 5% or more of FUSN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Fusion Pharmaceuticals Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Fusion Pharmaceuticals Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
25 Schedule 13D and 13G filings on Fusion Pharmaceuticals Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 8, 20249:10 AM ET | Federated Hermes, Inc. | 13G/AOld format | – | – | – | SEC |
| Mar 25, 20245:29 PM ET | Federated Hermes, Inc. | 13DOld format | – | – | – | SEC |
| Mar 20, 2024 | HealthCap VII, L.P. | 13D/AOld format | – | – | – | SEC |
| Mar 7, 2024 | HealthCap VII, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Canada Pension Plan Investment Board | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Avidity Partners Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Jan 19, 2024 | Perceptive Advisors LLC | 13GOld format | – | New | – | SEC |
| Jan 18, 202410:11 AM ET | Federated Hermes, Inc. | 13G/AOld format | – | – | – | SEC |
| Dec 18, 2023 | Flynn James E | 13GOld format | – | New | – | SEC |
| Oct 23, 2023 | Avidity Partners Management LP | 13GOld format | – | New | – | SEC |
| Jun 9, 20238:19 AM ET | Federated Hermes, Inc. | 13G/AOld format | – | – | – | SEC |
| May 16, 2023 | OrbiMed Advisors LLC | 13D/AOld format | – | – | – | SEC |
| Mar 6, 2023 | HealthCap VII, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 28, 2023 | OrbiMed Advisors LLC | 13D/AOld format | – | – | – | SEC |
| Feb 9, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Feb 1, 20238:56 AM ET | Federated Hermes, Inc. | 13GOld format | – | New | – | SEC |
| Jan 27, 202311:12 AM ET | Johnson & Johnson | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Adams Street Partners LLC | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Jan 18, 2022 | TPG GP A, LLC | 13D/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Adams Street Partners LLC | 13GOld format | – | New | – | SEC |
| Feb 9, 20214:10 PM ET | Varian Medical Systems Inc | 13GOld format | – | New | – | SEC |
| Feb 8, 2021 | FMR LLC | 13GOld format | – | New | – | SEC |
| Feb 4, 2021 | Canada Pension Plan Investment Board | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
2 notices from officers, directors and other affiliates planning to sell Fusion Pharmaceuticals Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Dec 14, 20235:31 PM ET | Chau Q. KhuongAffiliate | 22.1K | $121.5K | Dec 14, 2023 | J.P. Morgan Securities LLC | SEC |
| Dec 8, 20235:36 PM ET | Chau Q. KhuongAffiliate | 22.1K | $127.0K | Dec 8, 2023 | J.P. Morgan Securities LLC | SEC |